A detailed history of Jane Street Group, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Jane Street Group, LLC holds 101,315 shares of NVO stock, worth $8.85 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
101,315
Previous 301,201 66.36%
Holding current value
$8.85 Million
Previous $43 Million 71.94%
% of portfolio
0.0%
Previous 0.05%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$119.07 - $145.42 $23.8 Million - $29.1 Million
-199,886 Reduced 66.36%
101,315 $12.1 Million
Q2 2024

Aug 14, 2024

SELL
$122.71 - $146.91 $3.63 Million - $4.35 Million
-29,589 Reduced 8.94%
301,201 $43 Million
Q1 2024

May 15, 2024

SELL
$102.11 - $135.92 $23.3 Million - $31 Million
-228,174 Reduced 40.82%
330,790 $42.5 Million
Q4 2023

Feb 14, 2024

SELL
$87.78 - $105.45 $34.5 Million - $41.4 Million
-392,494 Reduced 41.25%
558,964 $57.8 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $77.8 Million - $171 Million
855,419 Added 890.7%
951,458 $86.5 Million
Q2 2023

Aug 14, 2023

SELL
$155.98 - $172.65 $14.4 Million - $16 Million
-92,631 Reduced 49.1%
96,039 $15.5 Million
Q1 2023

May 15, 2023

BUY
$132.34 - $159.14 $24.7 Million - $29.7 Million
186,365 Added 8085.25%
188,670 $30 Million
Q4 2022

Feb 14, 2023

SELL
$102.55 - $135.33 $17.5 Million - $23.1 Million
-170,421 Reduced 98.67%
2,305 $311,000
Q3 2022

Nov 14, 2022

SELL
$95.28 - $116.93 $13.7 Million - $16.8 Million
-143,324 Reduced 45.35%
172,726 $17.2 Million
Q3 2022

Nov 14, 2022

SELL
$95.28 - $116.93 $13.7 Million - $16.8 Million
-143,324 Reduced 45.35%
172,726 $17.2 Million
Q2 2022

Aug 16, 2022

BUY
$103.24 - $121.81 $23.8 Million - $28.1 Million
230,503 Added 269.45%
316,050 $35.2 Million
Q1 2022

May 17, 2022

BUY
$93.1 - $112.54 $6.23 Million - $7.53 Million
66,920 Added 359.26%
85,547 $9.5 Million
Q4 2021

Feb 15, 2022

BUY
$95.88 - $117.08 $396,367 - $484,008
4,134 Added 28.52%
18,627 $2.09 Million
Q3 2021

Nov 16, 2021

SELL
$84.42 - $106.62 $2.44 Million - $3.08 Million
-28,921 Reduced 66.62%
14,493 $1.39 Million
Q1 2021

May 18, 2021

SELL
$67.06 - $75.82 $19.1 Million - $21.6 Million
-284,321 Reduced 86.75%
43,414 $2.93 Million
Q4 2020

Feb 17, 2021

BUY
$63.89 - $73.8 $5.66 Million - $6.54 Million
88,641 Added 37.07%
327,735 $22.9 Million
Q3 2020

Nov 17, 2020

BUY
$63.69 - $70.22 $12.9 Million - $14.2 Million
202,241 Added 548.78%
239,094 $16.6 Million
Q2 2020

Aug 17, 2020

SELL
$58.54 - $67.94 $26.7 Million - $31 Million
-456,905 Reduced 92.54%
36,853 $2.41 Million
Q1 2020

May 15, 2020

BUY
$49.46 - $64.78 $24.2 Million - $31.7 Million
488,796 Added 9850.79%
493,758 $29.7 Million
Q4 2019

Feb 14, 2020

SELL
$49.86 - $58.26 $12.9 Million - $15.1 Million
-258,839 Reduced 98.12%
4,962 $287,000
Q3 2019

Nov 14, 2019

BUY
$47.54 - $53.43 $3.58 Million - $4.02 Million
75,311 Added 39.95%
263,801 $13.6 Million
Q2 2019

Aug 15, 2019

BUY
$46.79 - $52.47 $8.21 Million - $9.21 Million
175,553 Added 1356.98%
188,490 $9.62 Million
Q1 2019

May 16, 2019

SELL
$46.36 - $52.63 $5.25 Million - $5.96 Million
-113,201 Reduced 89.74%
12,937 $677,000
Q4 2018

Feb 15, 2019

BUY
$41.54 - $47.25 $4.95 Million - $5.63 Million
119,137 Added 1701.71%
126,138 $5.81 Million
Q3 2018

Nov 14, 2018

SELL
$46.76 - $51.24 $14.3 Million - $15.6 Million
-305,255 Reduced 97.76%
7,001 $330,000
Q2 2018

Aug 15, 2018

BUY
$44.29 - $50.42 $6.89 Million - $7.84 Million
155,510 Added 99.21%
312,256 $14.4 Million
Q1 2018

May 15, 2018

BUY
$48.49 - $58.14 $7.25 Million - $8.69 Million
149,529 Added 2071.9%
156,746 $7.72 Million
Q4 2017

Feb 15, 2018

SELL
$47.53 - $53.73 $1.52 Million - $1.72 Million
-31,974 Reduced 81.59%
7,217 $387,000
Q3 2017

Nov 14, 2017

BUY
$41.15 - $49.22 $1.61 Million - $1.93 Million
39,191
39,191 $1.89 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.